Weiwei Su

2.0k total citations
65 papers, 1.6k citations indexed

About

Weiwei Su is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Complementary and alternative medicine. According to data from OpenAlex, Weiwei Su has authored 65 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Complementary and alternative medicine. Recurrent topics in Weiwei Su's work include Advanced Numerical Analysis Techniques (7 papers), Traditional Chinese Medicine Analysis (6 papers) and Advanced machining processes and optimization (5 papers). Weiwei Su is often cited by papers focused on Advanced Numerical Analysis Techniques (7 papers), Traditional Chinese Medicine Analysis (6 papers) and Advanced machining processes and optimization (5 papers). Weiwei Su collaborates with scholars based in China, Hong Kong and United States. Weiwei Su's co-authors include Peibo Li, Yichu Nie, Xiang‐Qun Xie, Hao Wu, Lirong Wang, Yu-Long Luo, Jian-wei Ma, Zhenyuan Jia, Dening Song and Peter Wipf and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Scientific Reports.

In The Last Decade

Weiwei Su

62 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Weiwei Su 635 250 224 198 181 65 1.6k
Fengguo Xu 1.7k 2.7× 223 0.9× 80 0.4× 395 2.0× 395 2.2× 138 3.3k
Mona F. Mahmoud 604 1.0× 299 1.2× 44 0.2× 221 1.1× 424 2.3× 123 2.4k
Yonghong Gao 626 1.0× 121 0.5× 90 0.4× 189 1.0× 96 0.5× 102 1.9k
Jiye Zhang 752 1.2× 111 0.4× 35 0.2× 160 0.8× 143 0.8× 111 2.2k
Wenlong Li 440 0.7× 145 0.6× 61 0.3× 277 1.4× 145 0.8× 160 1.6k
Yanwei Xing 1.4k 2.2× 251 1.0× 55 0.2× 400 2.0× 268 1.5× 120 3.3k
Bei Jiang 561 0.9× 148 0.6× 47 0.2× 109 0.6× 142 0.8× 143 2.1k
Pierre Lebrun 435 0.7× 295 1.2× 97 0.4× 64 0.3× 38 0.2× 68 1.9k
Ana Laura de la Garza 396 0.6× 162 0.6× 65 0.3× 80 0.4× 76 0.4× 43 1.5k
Pei Luo 1.6k 2.6× 268 1.1× 60 0.3× 439 2.2× 289 1.6× 155 3.2k

Countries citing papers authored by Weiwei Su

Since Specialization
Citations

This map shows the geographic impact of Weiwei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Su more than expected).

Fields of papers citing papers by Weiwei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Su. The network helps show where Weiwei Su may publish in the future.

Co-authorship network of co-authors of Weiwei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Su. A scholar is included among the top collaborators of Weiwei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Su. Weiwei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jia, et al.. (2025). Identification and verification of biomarkers associated with arachidonic acid metabolism in non-alcoholic fatty liver disease. Scientific Reports. 15(1). 8521–8521. 1 indexed citations
5.
Dong, Min, et al.. (2021). Common mechanism of Citrus Grandis Exocarpium in treatment of chronic obstructive pulmonary disease and lung cancer. Chinese Herbal Medicines. 13(4). 525–533. 8 indexed citations
6.
Su, Weiwei, Yonggang Wang, Peibo Li, et al.. (2020). The potential application of the traditional Chinese herb Exocarpium Citri grandis in the prevention and treatment of COVID-19. SHILAP Revista de lepidopterología. 8 indexed citations
7.
Bi, Cong, Yan Liao, Peibo Li, et al.. (2019). Pharmacodynamic effects of Dan-hong injection in rats with blood stasis syndrome. Biomedicine & Pharmacotherapy. 118. 109187–109187. 22 indexed citations
8.
Ma, Jian-wei, et al.. (2018). Conversion method study from cutter-location points to nonuniform rational B-spline toolpath NC file for high-speed machining. Proceedings of the Institution of Mechanical Engineers Part C Journal of Mechanical Engineering Science. 233(2). 514–525. 4 indexed citations
9.
Wang, Jingwen, Jingwei Wang, Jun Zhang, et al.. (2018). Decreased Methylation of IFNAR Gene Promoter from Peripheral Blood Mononuclear Cells Is Associated with Oxidative Stress in Chronic Hepatitis B. Journal of Interferon & Cytokine Research. 38(11). 480–490. 4 indexed citations
10.
Qin, Guangming, Zhihao Chen, Weiwei Su, et al.. (2017). Clinical usefulness of metabolic risk factors to identify young asymptomatic women adults with subclinical atherosclerosis. Medicine. 96(11). e6237–e6237. 1 indexed citations
11.
Liu, Menghua, et al.. (2013). Construction of DNA finger printing for dry saffron. African Journal of Pharmacy and Pharmacology. 7(43). 2807–2812. 1 indexed citations
12.
Liang, Shuang, Weiwei Su, Yonggang Wang, et al.. (2013). Effect of quercetin 7-rhamnoside on glycochenodeoxycholic acid-induced L-02 human normal liver cell apoptosis. International Journal of Molecular Medicine. 32(2). 323–330. 13 indexed citations
14.
Luo, Yu-Long, Peibo Li, Chenchen Zhang, et al.. (2013). Effects of four antitussives on airway neurogenic inflammation in a guinea pig model of chronic cough induced by cigarette smoke exposure. Inflammation Research. 62(12). 1053–1061. 24 indexed citations
15.
Nie, Yichu, Hao Wu, Peibo Li, et al.. (2012). Anti-Inflammatory Effects of Naringin in Chronic Pulmonary Neutrophilic Inflammation in Cigarette Smoke-Exposed Rats. Journal of Medicinal Food. 15(10). 894–900. 84 indexed citations
16.
Li, Peibo, et al.. (2012). Antidiabetic activities of oligosaccharides of Ophiopogonis japonicus in experimental type 2 diabetic rats. International Journal of Biological Macromolecules. 51(5). 749–755. 35 indexed citations
17.
Wang, Ning, Yibin Feng, Fan Cheung, et al.. (2012). A comparative study on the hepatoprotective action of bear bile and coptidis rhizoma aqueous extract on experimental liver fibrosis in rats. BMC Complementary and Alternative Medicine. 12(1). 239–239. 25 indexed citations
18.
Yang, Cuiping, et al.. (2012). Quantification of Kryptofix 2.2.2 in [18F]fluorine-labelled radiopharmaceuticals by rapid-resolution liquid chromatography. Nuclear Medicine Communications. 33(5). 498–502. 4 indexed citations
19.
Song, Xun, Chenyang Li, Yong Zeng, et al.. (2012). Immunomodulatory effects of crude phenylethanoid glycosides from Ligustrum purpurascens. Journal of Ethnopharmacology. 144(3). 584–591. 26 indexed citations
20.
Luo, Yu-Long, Chenchen Zhang, Peibo Li, et al.. (2012). Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke. International Immunopharmacology. 13(3). 301–307. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026